4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-19-060476
EVP and CCO sold 105,479 shares at an average $44.46 ($4,689,263)
- EVP and CCO acquired 105,479 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| YANG MICHAEL J. EVP and CCO | 2019-12-12 | Option exercise | +22,500 | $19.98 | $449,550 | 24,999 | D |
| YANG MICHAEL J. EVP and CCO | 2019-12-12 | Option exercise | +10,000 | $21.28 | $212,800 | 34,999 | D |
| YANG MICHAEL J. EVP and CCO | 2019-12-12 | Option exercise | +72,979 | $35.86 | $2,617,027 | 107,978 | D |
| YANG MICHAEL J. EVP and CCO | 2019-12-12 | Sale | −100,447 | $44.49 | $4,469,188 | 7,531 | D |
| YANG MICHAEL J. EVP and CCO | 2019-12-12 | Sale | −5,032 | $43.74 | $220,075 | 2,499 | D |
| Derivatives | |||||||
| YANG MICHAEL J. EVP and CCO | 2019-12-12 | Option exercise · Stock Option (Right to Buy) | −22,500 | 577,500 | D | ||
| YANG MICHAEL J. EVP and CCO | 2019-12-12 | Option exercise · Stock Option (Right to Buy) | −10,000 | 30,000 | D | ||
| YANG MICHAEL J. EVP and CCO | 2019-12-12 | Option exercise · Stock Option (Right to Buy) | −72,979 | 312,500 | D | ||
| Open-market sales · 105,479 sh · avg $44.46 · $4,689,263 | |||||||
Loading xslF345X03/doc4.xml…